Heba A. Eassa
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Drug Discovery top 10%
Papers in
-
- Advancements in Transdermal Drug Delivery 4
- Advanced Drug Delivery Systems 4
-
- Enzyme Catalysis and Immobilization 1
- Co-authors
- Mohamed Ismail Nounou (7 shared papers)A. M. Amer (2 shared papers)Ivan O. Edafiogho (2 shared papers)Asmaa Saleh (2 shared papers)Eman Rashad (1 shared paper)Eman S. Nossier (1 shared paper)Abd El‐Galil E. Amr (1 shared paper)Heba E. Hashem (1 shared paper)
- Journals
- Current Pharmaceutical Design (1 paper)Drug Delivery (1 paper)Recent Patents on Drug Delivery & Formulation (1 paper)AAPS PharmSciTech (1 paper)Molecules (1 paper)
- Partner nations
- EgyptUnited StatesSaudi Arabia
In The Last Decade
Heba A. Eassa
17 papers receiving 255 citations
Peers
Comparison fields: 5 of 94
- Pharmaceutical Science 78
- Drug Discovery 2
- Dermatology 30
- Molecular Medicine 8
- Biochemistry 8
Countries citing papers authored by Heba A. Eassa
This map shows the geographic impact of Heba A. Eassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba A. Eassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba A. Eassa more than expected).
Fields of papers citing papers by Heba A. Eassa
This network shows the impact of papers produced by Heba A. Eassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba A. Eassa. The network helps show where Heba A. Eassa may publish in the future.
Co-authors
The 16 scholars most cited alongside Heba A. Eassa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 87 | |
| 2 | 2022 | 42 | |
| 3 | 2021 | 31 | |
| 4 | 2019 | 25 | |
| 5 | 2023 | 18 | |
| 6 | 2019 | 16 | |
| 7 | Current Topical Strategies for Skin-Aging and Inflammaging Treatment: Science versus Fiction. | 2020 | 10 |
| 8 | 2022 | 9 | |
| 9 | 2020 | 6 | |
| 10 | 2023 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2022 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2024 | 1 |
About Heba A. Eassa
Heba A. Eassa is a scholar working on Pharmaceutical Science, Molecular Biology, Dermatology, Computational Theory and Mathematics and Organic Chemistry, having authored 17 papers that have together received 259 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (4 papers), Advanced Drug Delivery Systems (4 papers), Computational Drug Discovery Methods (3 papers), Dermatology and Skin Diseases (2 papers), Infection Control and Ventilation (1 paper), Dental Research and COVID-19 (1 paper), Enzyme Catalysis and Immobilization (1 paper) and Wound Healing and Treatments (1 paper). The work is most often cited by research in Pharmaceutical Science (78 citations), Drug Discovery (2 citations), Dermatology (30 citations), Molecular Medicine (8 citations) and Biochemistry (8 citations). Heba A. Eassa has collaborated with scholars based in Egypt, United States and Saudi Arabia. Frequent co-authors include Mohamed Ismail Nounou, A. M. Amer, Ivan O. Edafiogho, Asmaa Saleh, Eman Rashad, Eman S. Nossier, Abd El‐Galil E. Amr, Heba E. Hashem, Abdulrahman A. Almehizia and Benson M. Kariuki. Their work appears in journals such as Current Pharmaceutical Design, Drug Delivery, Recent Patents on Drug Delivery & Formulation, AAPS PharmSciTech and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.